Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer

PURPOSE: The interaction of programmed death receptor 1 (PD-1) and its ligand, programmed death receptor ligand 1 (PD-L1), negatively regulates immune responses. This study aimed to clarify PD-L1 expression levels in breast cancer through immunohistochemistry (IHC) and to evaluate associations betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Sang Byung, Cho, Hyun Deuk, Oh, Mee-Hye, Lee, Ji-Hye, Jang, Si-Hyong, Hong, Soon Auck, Cho, Junhun, Kim, Sung Yong, Han, Sun Wook, Lee, Jong Eun, Kim, Han Jo, Lee, Hyun Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053308/
https://www.ncbi.nlm.nih.gov/pubmed/27721873
http://dx.doi.org/10.4048/jbc.2016.19.3.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053308/
https://www.ncbi.nlm.nih.gov/pubmed/27721873
http://dx.doi.org/10.4048/jbc.2016.19.3.242

Ejemplares similares